Speaker illustration

Professor Stephan Jacob

Villingen (Germany)

Q&A and panel discussion.

Event: ESC Congress 2022

Topic: Diabetes and the Heart

Session: GLP-1 RAs: more than just glucose-lowering agents

Thumbnail

Practical considerations for the use of GLP-1 RAs in the clinic.

Event: ESC Congress 2022

Topic: Diabetes and the Heart

Session: GLP-1 RAs: more than just glucose-lowering agents

Thumbnail

What should we do when we are presented with an individual who has CVD and comorbid obesity?

Event: ESC Congress 2021 - The Digital Experience

Topic: Risk Factors and Prevention

Session: Navigating obesity treatment for prevention of CVD

Thumbnail

Type 2 Diabetes & CV outcomes: more than Glucose management? Lessons from GLP1-ra trials.

Event: EuroPrevent 2019

Topic: Diabetes and the Heart

Session: The preventive challenge in diabetes & CVD: a multidisciplinary approach.

Thumbnail

Discussion - GLP-1 RA in diabetes and cardiovascular disease - What are the key opportunities for cardiology practice

Event: ESC Congress 2018

Topic: Diabetes and the Heart

Session: Outcomes of GLP-1 RA in diabetes and cardiovascular disease - Discussing the key opportunities for cardiology practice

Thumbnail

Summary - GLP-1 receptor agonists - The cardiovascular benefits beyond glucose control.

Event: ESC Congress 2018

Topic: Diabetes and the Heart

Session: Outcomes of GLP-1 RA in diabetes and cardiovascular disease - Discussing the key opportunities for cardiology practice

Thumbnail

Panel discussion: discussing the benefits in cardiovascular risk, diabetes & heart failure.

Event: ESC Congress 2018

Topic: Diabetes and the Heart

Session: Targeting SGLT2 in clinical cardiology: discussing the benefits in cardiovascular risk, diabetes & heart failure

Thumbnail

Changing focus in diabetes: From glucose to cardiovascular risk management.

Event: ESC Congress 2018

Topic: Diabetes and the Heart

Session: Targeting SGLT2 in clinical cardiology: exploring the benefits in cardiovascular risk, diabetes & heart failure (EBAC Accredited)

Thumbnail

This platform is supported by

logo Novo Nordisk